Concord Biotech sets November 4 as record date for 1:1 bonus issue
Investors must purchase the smallcap pharma stock by today to qualify for the bonus shares being allotted on Thursday.
Smallcap pharmaceutical firm Concord Biotech has fixed Wednesday, November 4, as the record date for its 1:1 bonus issue, according to The Economic Times. Under the Sebi T+1 settlement cycle, today is the final day for investors to buy the stock to ensure shares are credited to their demat accounts in time for eligibility.
The company's board approved the issuance of 10.46 crore bonus shares with a face value of Re 1 each in September. These shares will be allotted to eligible shareholders on Thursday, November 5.
Concord Biotech, which has a market capitalisation of approximately Rs 12,172 crore, was backed by the late investor Rakesh Jhunjhunwala. Data from Trendlyne shows that Jhunjhunwala and his associates held about 24% stake in the firm as of the end of the September quarter of FY27.
The company's stock has seen a decline of more than 11% over the last week and over 15% during the past month. The share price has also dropped nearly 13% so far in 2026 and fell 19% over the last year, though it provided returns of just over 3% over a three-year period.